CV Impact of Immune Checkpoint Inhibitor Cardiotoxicity
Published 2021-12-08Download video
Recommendations
-
05:16 New Treatment for AFib: Convergent Ablation
-
00:37 Behind-the-Heart: Inspiring Collaboration Within the Cardiovascular Space | A Radcliffe Exclusive
-
57:07 CGC 2023 Webinar Series: Real world classification of variants in cancer
-
55:11 Oral Anticoagulation in 2024: Lessons from the Randomized Trials: Dr. John Eikelboom
-
02:50 ISET 24: TOBA II BTK: Sub-Analysis Shows Tack Repair Performs Well in Complex Lesions
-
02:00 Solving Problems with Dr Pugazhendi Vijayaraman
-
1:04:36 TIO MCS | Guidance on MCS Selection
-
1:05:21 Parallax | Ep 105: The Year 2023 in Review with Dr Sukh Nijjer
-
23:44 19 What the 2023 Guidelines for the Management of Arterial Hypertension Say Costas Tsouifis
-
00:35 Behind-the-Heart: Bringing Cardiovascular Innovation to You | A Radcliffe Exclusive
-
00:35 Behind-the-Heart: Providing Advice for Young Investigators | A Radcliffe Exclusive
-
06:41 VIVA 23: PROMISE II: 12M Results From Pivotal Trial of LimFlow System
-
1:06:14 Treatment Options for Essential Tremor - UNC Health
-
00:40 Making a Difference with Dr Alexander Fanaroff
-
02:53 TIO MCS | Introduction
-
12:21 ISET 24: LIFE-BTK: Drug-Eluting Resorbable Scaffolds in 2024
-
15:27 ESC Congress 2023 Highlights
-
47:02 Parallax | Ep 106: Transforming Health Systems Through Economics with Dr Alex Carter
-
1:07:00 Sepsis is a metabolic disease by Professor Dr. Kathleen Stringer
Similar videos
-
48:55 JACC: CardioOncology Video Case Presentation | Early Immune Checkpoint Inhibitor Cardiotoxicity
-
1:01:45 Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-Oncology
-
03:29 Cardiac toxicity of immune-checkpoint inhibitors – ID 185202
-
55:26 Immune Checkpoint Inhibitor Cardiotoxicity
-
01:53 Toxicities and new immune checkpoint inhibitors
-
1:02:01 Cardiotoxicity from Immunotherapy: Can Advanced Cardiac Imaging Meet the Challenge?
-
1:02:47 “Rheumatologic Consequences of Immune Checkpoint Inhibitors”, Annual Kessler Lecture, Dr. Ami Shah
-
03:54 Neurological adverse events associated with immune checkpoint inhibitors
-
03:48 Overcoming resistance to immune checkpoint inhibitors in NSCLC
-
17:14 Cardiovascular Toxicity and Immune Checkpoint Inhibitors
-
17:34 Cardio oncology – Risk Prediction and Surveillance for Cardiotoxicity in Cancer Patients
-
25:16 Immune Check Point Inhibitor Cardiotoxicity
-
1:03:52 Cardiac Toxicities Among Patients Treated with Immune Checkpoint
-
01:57 BTOG 2021 highlights: immunotherapy for mesothelioma and cardiac toxicity updates
-
56:25 Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity? Dr. Lili Zhang
-
59:45 Cardio-oncology care: how to prevent and how to treat CV diseases?
-
59:13 Improving the Management of Cardiac Immune-Related Adverse Events in Patients With Cancer
-
02:19 An Overview of Cardiotoxicity